ANNX
Annexon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.23
+1.44%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.28
- Revenue estimate
- $3.5M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.28
- EPS estimate
- -$0.24
- Revenue actual
- —
- Revenue estimate
- $6.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $14
- PT range
- $3.00 – $25
- Analysts
- 3
2 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.24 | -$0.28 | Miss -17.23% | — |
| May 7, 2026 | -$0.30 | -$0.23 | Beat 23.33% | — |
| Mar 30, 2026 | -$0.32 | -$0.28 | Beat 12.50% | — |
| Aug 14, 2025 | -$0.36 | -$0.34 | Beat 5.56% | — |
| Mar 3, 2025 | -$0.28 | -$0.33 | Miss -17.86% | — |
| Nov 14, 2024 | -$0.26 | -$0.25 | Beat 3.85% | — |
| Nov 13, 2023 | -$0.50 | -$0.43 | Beat 14.00% | — |
| Mar 6, 2023 | -$0.52 | -$0.48 | Beat 7.69% | — |
| Nov 3, 2022 | -$0.87 | -$0.51 | Beat 41.38% | — |
| Mar 1, 2022 | -$0.90 | -$0.97 | Miss -7.78% | — |
| Aug 16, 2021 | -$0.68 | -$0.82 | Miss -20.59% | — |
| May 17, 2021 | -$0.60 | -$0.68 | Miss -13.33% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026